For Mankind, this is a strategic investment in the field of treatment of cancer cachexia, amyotrophic lateral sclerosis, and other muscle-wasting disorders.
Mankind Pharma gains on raising stake in British therapeutics firm on December 18, 2023 at 6:06 am
